Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anticoagulation in people with atrial fibrillation.
Fang MC.
BMJ. 2011 Jan 31;342:d530. doi: 10.1136/bmj.d530. No abstract available.
Related citations
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C.
BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124.
New European guidelines on atrial fibrillation.
Hunter RJ, Schilling RJ.
BMJ. 2011 Feb 21;342:d897. doi: 10.1136/bmj.d897. No abstract available.
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.
Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW; PROSPER Executive.
BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250.
Anticoagulation in AF. Anticoagulation uptake remains poor in high risk patients.
Cowan C, Fay M, Griffith K, Jenkinson D.
BMJ. 2011 Feb 22;342:d1153. doi: 10.1136/bmj.d1153. No abstract available.
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Hobbs FD, Roalfe AK, Lip GY, Fletcher K, Fitzmaurice DA, Mant J; Birmingham Atrial Fibrillation in the Aged Investigators and Midland Research Practices Consortium Network.
BMJ. 2011 Jun 23;342:d3653. doi: 10.1136/bmj.d3653.
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT.
BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.
NSAIDs and atrial fibrillation.
Gurwitz JH.
BMJ. 2011 Jul 4;343:d2495. doi: 10.1136/bmj.d2495. No abstract available.
Atrial fibrillation guidelines. Don't forget HASBLED score.
Claridge SB, Kanaganayagam GS, Kotecha T.
BMJ. 2011 May 24;342:d3205. doi: 10.1136/bmj.d3205. No abstract available.
Dementia with cardiac problems.
Bute J, Waller D.
BMJ. 2011 Jul 22;343:d4278. doi: 10.1136/bmj.d4278. No abstract available.
Cost of dabigatran for atrial fibrillation.
Gage BF.
BMJ. 2011 Oct 31;343:d6980. doi: 10.1136/bmj.d6980. No abstract available.
Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
Pink J, Lane S, Pirmohamed M, Hughes DA.
BMJ. 2011 Oct 31;343:d6333. doi: 10.1136/bmj.d6333.
A case of recurrent ventricular tachycardia.
Inglis C, Chedgy F, Howlett DC.
BMJ. 2011 Jun 1;342:d2654. doi: 10.1136/bmj.d2654. No abstract available.
Take real world issues into account.
Zermansky A, Khatib R.
BMJ. 2011 Dec 13;343:d7716; author reply d7718. doi: 10.1136/bmj.d7716. No abstract available.
Dabigatran etexilate in people with atrial fibrillation.
Raju NC, Hankey GJ.
BMJ. 2010 Jul 29;341:c3784. doi: 10.1136/bmj.c3784. No abstract available.
Dabigatran v warfarin. Compare with higher standard.
Edwards D.
BMJ. 2010 Oct 26;341:c5984. doi: 10.1136/bmj.c5984. No abstract available.
Implantable cardioverter defibrillators after acute myocardial infarction.
Liew R.
BMJ. 2010 Nov 19;341:c5741. doi: 10.1136/bmj.c5741. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on